STEVENS-JOHNSON SYNDROME
Clinical trials for STEVENS-JOHNSON SYNDROME explained in plain language.
Never miss a new study
Get alerted when new STEVENS-JOHNSON SYNDROME trials appear
Sign up with your email to follow new studies for STEVENS-JOHNSON SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New injection tested to heal devastating skin condition
Disease control CompletedThis study tested whether G-CSF injections could help patients with toxic epidermal necrolysis, a rare but severe skin reaction where large areas of skin peel off. Ten patients were randomly assigned to receive either the G-CSF treatment or a placebo injection for five days. Rese…
Matched conditions: STEVENS-JOHNSON SYNDROME
Phase: PHASE4 • Sponsor: University of Liege • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
Drug tested for deadly Skin-Shedding disease
Disease control CompletedThis small, completed pilot study tested whether the drug tofacitinib could help patients with Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN). These are rare, life-threatening conditions where the skin and mucous membranes blister and peel off. All 20 partici…
Matched conditions: STEVENS-JOHNSON SYNDROME
Phase: NA • Sponsor: Chang Gung Memorial Hospital • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
Breakthrough trial aims to tame deadly Skin-Shedding reaction
Disease control CompletedThis study tested whether a drug called etanercept could help patients with severe, life-threatening skin reactions (SJS/TEN) heal faster. It compared etanercept against the current standard of supportive care alone. The main goal was to see which approach led to the quickest com…
Matched conditions: STEVENS-JOHNSON SYNDROME
Phase: PHASE3 • Sponsor: Vanderbilt University Medical Center • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC